Brielle Urciuoli
Articles
Ketamine May Benefit Those With Difficult Pain From Ovarian Cancer
October 16, 2018
Article
Ketamine, typically used to kickstart and maintain anesthesia use, could be an option for treating patients with ovarian cancer whose pain is difficult to treat.
Scanxiety Tips from an Expert
September 19, 2018
Article
An expert discusses tips on how patients with cancer can manage their "scanxiety."
JAK Inhibition in Myelofibrosis Treatment May Cause Aggressive Lymphoma in Small Percentage of Patients
September 03, 2018
Article
Although JAK inhibitors are a proven effective treatment for patients with myelofibrosis, a type of myeloproliferative neoplasm (MPN), they may come with a severe downside; in particular, a 16-fold increase in the chance of developing a B-cell lymphoma, according to recent research published in the journal Blood.
Minorities Not Adequately Represented in Lung Cancer Screening Guidelines
August 29, 2018
Article
The trial that led to national screening guidelines—which recommend screening based on age and smoking history—did not include fair representation from all racial/ethnic groups.
Exploring the Need for Better Melanoma Surveillance
May 18, 2018
Article
Surveillance of potentially cancerous skin lesions is key in early detection and treatment of the disease, which vastly improves outcomes.
Suicide Screening Needed for Head and Neck Cancer Survivors
April 29, 2018
Article
Head and neck cancer survivors have about a 45% higher suicide ratio compared to all other cancers.
Proposed Bill Would Reimburse Providers for Creating Survivorship Plans for Patients with Medicare
April 13, 2018
Article
Two congressmen, who are also cancer survivors, proposed the Cancer Care Planning and Communications (CCPC) Act, which would create a Medicare billing code that would reimburse providers for their time and resources used to create survivorship care plans for patients with Medicare.
FDA Approves Rubraca for Ovarian Cancer Maintenance Treatment
April 06, 2018
Article
The Food and Drug Administration (FDA) approved Rubraca (rucaparib) as a maintenance therapy for women with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer who are in complete or partial response to platinum-based chemotherapy, according to Clovis Oncology, the company that manufactures the drug.
The Importance of Survivorship Planning
April 04, 2018
Article
From diagnosis to post-treatment, survivors should have access to resources that help them navigate through their cancer journey.
Ponatinib Shows Promise for Rare Ovarian Cancer Type that Affects Young Women
March 08, 2018
Article
A drug used to treat leukemia may also have potential in treating small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).